The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has declared an advocacy win, with language it crafted to promote nuclear medicine research included in the recently approved 2024 Defense Appropriations Act.
“In 2023, SNMMI worked closely with Congress for legislative language that increases recognition for the value of diagnostic and therapeutic nuclear medicine research in federal agencies,” the SNMMI said, in a news release.
The legislative language encourages the director of the Department of Defense’s Congressionally Directed Medical Research Programs (CDMRP) to emphasize nuclear medicine to further drive the development of precision imaging and advanced targeted therapies, SNMMI said. Specifically, it encourages the CDMRP “to include nuclear medicine imaging and related techniques in descriptions of funding opportunities, where relevant, to support early diagnosis, enhance treatment, and improve outcomes for service members and their families.”
“The inclusion of SNMMI’s CDMRP report language is a positive step for the nuclear medicine community,” the SNMMI said.
SNMMI held its annual Hill Day on April 5 in Washington, with 65 members, patients, and industry colleagues gathering in Washington to lobby on key issues in the field.
